FDA 483 - Pharmaron (Beijing) TSP Services Limited - August 01, 2025

An FDA inspection of Pharmaron (Beijing) TSP Services Limited in Beijing identified multiple deficiencies in Good Laboratory Practice (GLP) compliance. The firm failed to ensure accurate data recording, proper archiving of study materials, and adequate storage conditions for equipment and supplies. Additionally, issues were noted with adherence to standard operating procedures, animal care equipment sanitation, and the overall suitability of the facility for nonclinical laboratory studies.